AxoGen Makes First Commercial Shipment of Nerve Graft Product to Italy

AxoGen, a company focused on the development of products and technologies for peripheral nerve reconstruction and regeneration, announced approval by the Rizzoli Orthopaedic Institute of its first commercial shipment of Avance Nerve Graft to a distribution partner in Italy.

Advertisement

Avance Nerve Graft is a processed nerve allograft for bridging nerve discontinuities. By eliminating a second surgery to harvest the patient’s own nerve tissue for use in the repair, Avance Nerve Graft offers an alternative to traditional autograft nerve repair procedures.

More Articles on Orthopedic Devices:

miVIP Surgery Performs Surgery With da Vinci Technology

Spinal Implants Market to Near $7B by 2018, MIS Market to Top $2.6B

10 New Orthopedic & Spine Device Launches

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Watch On-Demand Webinar

ASC development + private equity: How to build value from day one

Presenters: Andrew HrankaWendy Bruno Thomson, MBA, LHARichard Romero, CVA, ABV, FHFMA, PAHM

Advertisement

Next Up in Spinal Tech

Advertisement

Comments are closed.